glp-1 receptor expression Agonists as Treatments for Type 2 Diabetes Glucagon-Like Peptide-1 Receptor Agonists–Health Professional
Description
That broader medical context is what separates physician-supervised care from short-term dieting
GLP-1 agents examined in the analysis included semaglutide (Wegovy), dulaglutide (Trulicity), tirzepatide (Zepbound), exenatide (Byetta), liraglutide (Saxenda), and lixisenatide (Lyxumia)
Akkermansia muciniphila secretes P9 protein, which directly stimulates GLP-1 production from intestinal L cells
In: Feingold KR, Adler RA, Ahmed SF, et al., eds
Additionally, some individuals may experience side effects, such as nausea or digestive issues, which often require adjusting the dosage under medical supervision
